منابع مشابه
Cardiovascular Events in Japan
uring the rapid development of imaging modalities in cardiology, nuclear cardiology has played an important role in direct visualization of myocardial ischemia. Its contribution to prognostic evaluation in the USA and Europe has been established and major predictors of cardiovascular events have been assembled in nuclear cardiology guidelines.1 The value of prognostic evaluation and risk strati...
متن کاملOccupational class and incidence rates of cardiovascular events in middle aged men in Japan.
We investigated whether occupational class affects the incidence of cardiovascular events in Japanese factory workers. We prospectively evaluated 1,794 male workers aged 40-59, including 632 non-manual and 1,162 manual workers, employed in a metal products factory in Japan. The hazard ratios of stroke, myocardial infarction (MI) and cardiovascular events (combined stroke, MI and sudden cardiac ...
متن کاملAtherosclerotic Cardiovascular Risk in Japan
Increased global mortality is associated with atherosclerosis, which appears to be independent of race. Cardiovascular disease is one of the leading causes of mortality and morbidity in Japan. Atherosclerosis, an inflammatory disease characterized by abnormal lipid accumulation and inflammation in the arterial wall, is the main underlying cause of cardiovascular disease. Numerous cardiovascular...
متن کاملEvaluation of the Relationship between Hematological Indices and Cardiovascular Events in Isfahan Cohort Study
Background and Objective: Cardiovascular Disease (CVD) is the leading cause of death in developing countries. Inflammation significantly contributes to the process of atherosclerosis. Therefore, evaluating White Blood Cells (WBC) and platelet counts as markers of inflammatory as well as hematocrit as a marker of blood viscosity may predict coronary events. The present study aimed to evaluate th...
متن کاملReporting of Cardiovascular Medical Device Adverse Events to Pharmaceuticals and Medical Devices Agency, Japan☆
BACKGROUND Marketing authorization holders (MAHs) are obligated to report adverse events (AEs) within 15 days (some cases 30 days) to the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan. METHODS To analyze the timeliness of AE reporting to the PMDA, 6610 reports for five categories of cardiovascular devices were retrieved. Two durations were calculated: (1) time from the date the A...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation Journal
سال: 2012
ISSN: 1346-9843,1347-4820
DOI: 10.1253/circj.cj-12-0260